Protective effects of Bifidobacterium breve on imiquimod-induced psoriasis in mice through secondary bile acid production and FXR-TLR4/NF-κB pathway

This study aimed to evaluate the effects of Bifidobacterium breve CCFM683 on psoriasis and to investigate the underlying mechanisms. B. breve CCFM683 significantly ameliorated psoriasis in mice as well as elevated the deoxycholic acid (DCA) and lithocholic acid (LCA) in the colon compared with those...

Full description

Saved in:
Bibliographic Details
Main Authors: Xinqi Chen, Yang Chen, Catherine Stanton, R.Paul Ross, Jianxin Zhao, Bo Yang, Wei Chen
Format: Article
Language:English
Published: Tsinghua University Press 2024-11-01
Series:Food Science and Human Wellness
Subjects:
Online Access:https://www.sciopen.com/article/10.26599/FSHW.2023.9250029
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841550150179225600
author Xinqi Chen
Yang Chen
Catherine Stanton
R.Paul Ross
Jianxin Zhao
Bo Yang
Wei Chen
author_facet Xinqi Chen
Yang Chen
Catherine Stanton
R.Paul Ross
Jianxin Zhao
Bo Yang
Wei Chen
author_sort Xinqi Chen
collection DOAJ
description This study aimed to evaluate the effects of Bifidobacterium breve CCFM683 on psoriasis and to investigate the underlying mechanisms. B. breve CCFM683 significantly ameliorated psoriasis in mice as well as elevated the deoxycholic acid (DCA) and lithocholic acid (LCA) in the colon compared with those of the imiquimod (IMQ)-treated mice. Meanwhile, B. breve CCFM683 increased the relative abundance of DCA-producing Lachnoclostridium and diminished the harmful Desulfovibrio and Prevotellaceae UCG001. Additionally, the farnesoid X receptor (FXR) in the skin was activated and the expression of the Toll-like receptor 4 (TLR4)/ nuclear factor kappa-B (NF-κB) pathway was inhibited, and the downstream interleukin (IL)-17 and tumor necrosis factor (TNF)-α were downregulated whereas IL-10 was up- regulated. Moreover, the subsequent hyperproliferation of keratinocytes and the dysfunction of the epidermal barrier were improved. In conclusion, CCFM683 administration ameliorated IMQ-induced psoriasis via modulating gut microbiota, promoting the DCA production, regulating the FXR -TLR4/NF-κB pathway, diminishing proinflammatory cytokines, and regulating keratinocytes and epidermal barrier. These findings may be conducive to elucidating the mechanism for probiotics to ameliorate psoriasis and to promote its clinical trials in skin disease.
format Article
id doaj-art-efd2908001d24c718452db211044add9
institution Kabale University
issn 2097-0765
2213-4530
language English
publishDate 2024-11-01
publisher Tsinghua University Press
record_format Article
series Food Science and Human Wellness
spelling doaj-art-efd2908001d24c718452db211044add92025-01-10T06:57:02ZengTsinghua University PressFood Science and Human Wellness2097-07652213-45302024-11-011363447346010.26599/FSHW.2023.9250029Protective effects of Bifidobacterium breve on imiquimod-induced psoriasis in mice through secondary bile acid production and FXR-TLR4/NF-κB pathwayXinqi Chen0Yang Chen1Catherine Stanton2R.Paul Ross3Jianxin Zhao4Bo Yang5Wei Chen6State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, ChinaState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, ChinaInternational Joint Research Center for Probiotics & Gut Health, Jiangnan University, Wuxi 214122, ChinaInternational Joint Research Center for Probiotics & Gut Health, Jiangnan University, Wuxi 214122, ChinaState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, ChinaState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, ChinaState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, ChinaThis study aimed to evaluate the effects of Bifidobacterium breve CCFM683 on psoriasis and to investigate the underlying mechanisms. B. breve CCFM683 significantly ameliorated psoriasis in mice as well as elevated the deoxycholic acid (DCA) and lithocholic acid (LCA) in the colon compared with those of the imiquimod (IMQ)-treated mice. Meanwhile, B. breve CCFM683 increased the relative abundance of DCA-producing Lachnoclostridium and diminished the harmful Desulfovibrio and Prevotellaceae UCG001. Additionally, the farnesoid X receptor (FXR) in the skin was activated and the expression of the Toll-like receptor 4 (TLR4)/ nuclear factor kappa-B (NF-κB) pathway was inhibited, and the downstream interleukin (IL)-17 and tumor necrosis factor (TNF)-α were downregulated whereas IL-10 was up- regulated. Moreover, the subsequent hyperproliferation of keratinocytes and the dysfunction of the epidermal barrier were improved. In conclusion, CCFM683 administration ameliorated IMQ-induced psoriasis via modulating gut microbiota, promoting the DCA production, regulating the FXR -TLR4/NF-κB pathway, diminishing proinflammatory cytokines, and regulating keratinocytes and epidermal barrier. These findings may be conducive to elucidating the mechanism for probiotics to ameliorate psoriasis and to promote its clinical trials in skin disease.https://www.sciopen.com/article/10.26599/FSHW.2023.9250029psoriasisbifidobacterium brevegut microbiotasecondary bile acidsfxr-tlr4/nf-κb pathway
spellingShingle Xinqi Chen
Yang Chen
Catherine Stanton
R.Paul Ross
Jianxin Zhao
Bo Yang
Wei Chen
Protective effects of Bifidobacterium breve on imiquimod-induced psoriasis in mice through secondary bile acid production and FXR-TLR4/NF-κB pathway
Food Science and Human Wellness
psoriasis
bifidobacterium breve
gut microbiota
secondary bile acids
fxr-tlr4/nf-κb pathway
title Protective effects of Bifidobacterium breve on imiquimod-induced psoriasis in mice through secondary bile acid production and FXR-TLR4/NF-κB pathway
title_full Protective effects of Bifidobacterium breve on imiquimod-induced psoriasis in mice through secondary bile acid production and FXR-TLR4/NF-κB pathway
title_fullStr Protective effects of Bifidobacterium breve on imiquimod-induced psoriasis in mice through secondary bile acid production and FXR-TLR4/NF-κB pathway
title_full_unstemmed Protective effects of Bifidobacterium breve on imiquimod-induced psoriasis in mice through secondary bile acid production and FXR-TLR4/NF-κB pathway
title_short Protective effects of Bifidobacterium breve on imiquimod-induced psoriasis in mice through secondary bile acid production and FXR-TLR4/NF-κB pathway
title_sort protective effects of bifidobacterium breve on imiquimod induced psoriasis in mice through secondary bile acid production and fxr tlr4 nf κb pathway
topic psoriasis
bifidobacterium breve
gut microbiota
secondary bile acids
fxr-tlr4/nf-κb pathway
url https://www.sciopen.com/article/10.26599/FSHW.2023.9250029
work_keys_str_mv AT xinqichen protectiveeffectsofbifidobacteriumbreveonimiquimodinducedpsoriasisinmicethroughsecondarybileacidproductionandfxrtlr4nfkbpathway
AT yangchen protectiveeffectsofbifidobacteriumbreveonimiquimodinducedpsoriasisinmicethroughsecondarybileacidproductionandfxrtlr4nfkbpathway
AT catherinestanton protectiveeffectsofbifidobacteriumbreveonimiquimodinducedpsoriasisinmicethroughsecondarybileacidproductionandfxrtlr4nfkbpathway
AT rpaulross protectiveeffectsofbifidobacteriumbreveonimiquimodinducedpsoriasisinmicethroughsecondarybileacidproductionandfxrtlr4nfkbpathway
AT jianxinzhao protectiveeffectsofbifidobacteriumbreveonimiquimodinducedpsoriasisinmicethroughsecondarybileacidproductionandfxrtlr4nfkbpathway
AT boyang protectiveeffectsofbifidobacteriumbreveonimiquimodinducedpsoriasisinmicethroughsecondarybileacidproductionandfxrtlr4nfkbpathway
AT weichen protectiveeffectsofbifidobacteriumbreveonimiquimodinducedpsoriasisinmicethroughsecondarybileacidproductionandfxrtlr4nfkbpathway